It accelerates the inhibition of prostate cancer cell marker CD44 in vivo and in vitro and also downregulates the hedgehog-Gli1 pathway that contributes to the anticancer stem cell effect of genistein in prostate cancer TCs [175]. This evidence concerns the gene CD44 and prostate cancer.